TiGenix NV
DelistedCIK 1581987fmd_0X54A1RCYDXPK5S1HXHXATJ1N8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods
Latest annual · FY2017
Millions- Operating income
- (53)
- Net income
- (75)
- Free cash flow
- (33)
TiGenix NV financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Operating income | -€53.2 million | -€3 million | 20-F/A 2018-05-11 · proof | |
| Net income | -€74.8 million | €3.8 million | -2,068.1% | 20-F/A 2018-05-11 · proof |
| Cash from operating activities | -€30.3 million | €3.5 million | -952.6% | 20-F/A 2018-05-11 · proof |
| Free cash flow | -€33.4 million | €2 million | -1,730.9% | 20-F/A 2018-05-11 · proof |
| Total assets | €81.9 million | €136.2 million | -39.9% | 20-F/A 2018-05-11 · proof |
| Total liabilities | €60.5 million | €56.5 million | +7.1% | 20-F/A 2018-05-11 · proof |
| Cash and cash equivalents | €34.1 million | €78 million | -56.3% | 20-F/A 2018-05-11 · proof |
| Total debt | €41.8 million | €34.8 million | +19.8% | 20-F/A 2018-05-11 · proof |
- What was TiGenix NV's operating income in fiscal 2017?
- TiGenix NV reported operating income of -€53.2 million for fiscal 2017 (the year ended Dec 31, 2017), against -€3 million the year before. Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What was TiGenix NV's net income in fiscal 2017?
- TiGenix NV reported net income of -€74.8 million for fiscal 2017 (the year ended Dec 31, 2017), against €3.8 million the year before (-2,068.1%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What was TiGenix NV's cash from operating activities in fiscal 2017?
- TiGenix NV reported cash from operating activities of -€30.3 million for fiscal 2017 (the year ended Dec 31, 2017), against €3.5 million the year before (-952.6%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What was TiGenix NV's free cash flow in fiscal 2017?
- TiGenix NV reported free cash flow of -€33.4 million for fiscal 2017 (the year ended Dec 31, 2017), against €2 million the year before (-1,730.9%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What are TiGenix NV's total assets?
- As of Dec 31, 2017, TiGenix NV reported total assets of €81.9 million, against €136.2 million a year earlier (-39.9%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What are TiGenix NV's total liabilities?
- As of Dec 31, 2017, TiGenix NV reported total liabilities of €60.5 million, against €56.5 million a year earlier (+7.1%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What are TiGenix NV's cash and cash equivalents?
- As of Dec 31, 2017, TiGenix NV reported cash and cash equivalents of €34.1 million, against €78 million a year earlier (-56.3%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
- What is TiGenix NV's total debt?
- As of Dec 31, 2017, TiGenix NV reported total debt of €41.8 million, against €34.8 million a year earlier (+19.8%). Source: the 20-F/A filed with the SEC on May 11, 2018. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1581987&period_type=annual&limit=5"Information only, not investment advice.